Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension

• المؤلفون الرئيسيون: Intira Sriprasert, Hind Beydoun, Vanessa Barnabei, Rami Nassir, Andrea Z. LaCroix, David F. Archer
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Agricultural and Biological Sciences
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942509445&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/44870
• المؤسسة: Chiang Mai University

© 2015 by The North American Menopause Society. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. Objective: Endometrial spotting or bleeding is a common adverse effect among women taking continuouscombined estrogen-progestin therapy. The renin- angiotensin-aldosterone system plays a...